Our Global Health Room is about realizing the universal human right to health.
We aim to help people, families, regions and nations reach their health potentials via access to vaccines, health technologies and medicines. We specialize in providing market expertise and achieving successful health supply chains.
COVAX used innovative APAs as their means to rapidly secure Covid-19 vaccine volumes for countries that otherwise may have been left behind. The Yellow House provided advice on operationalizing the APAs with partners, self-procuring countries, AMC countries and humanitarian buffer deliveries.
Recent project
WHO: Access to Medicines, a key building block of universal health coverage
Equitable access to essential medical products, vaccines and technologies of assured quality, safety, efficacy and cost-effectiveness, and their scientifically sound and cost-effective use is one of the six health systems building blocks. To support countries to build their health systems to achieve universal health coverage (UHC) through a primary health care (PHC) approach, we designed the scope, structure, functions, and ways of working so that WHO’s ‘access to essential medicines’ is fully integrated in UHC and PHC.
Access to Health Products - a key building block of universal health coverage Client: WHO (UHC/LC)
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Access to Health Products - a key building block of universal health coverage Client: WHO (UHC/LC)
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Access to Health Products - a key building block of universal health coverage Client: WHO (UHC/LC)
Equitable access to essential medical products, vaccines and technologies of assured quality, safety, efficacy and cost-effectiveness, and their scientifically sound and cost-effective use is one of the six health systems building blocks. To support countries to build their health systems to achieve universal health coverage (UHC) through a primary health care (PHC) approach, we designed the scope, structure, functions, and ways of working so that WHO’s ‘access to essential medicines’ is fully integrated in UHC and PHC.
Access to Health Products - a key building block of universal health coverage Client: WHO (UHC/LC)
Equitable access to essential medical products, vaccines and technologies of assured quality, safety, efficacy and cost-effectiveness, and their scientifically sound and cost-effective use is one of the six health systems building blocks. To support countries to build their health systems to achieve universal health coverage (UHC) through a primary health care (PHC) approach, we designed the scope, structure, functions, and ways of working so that WHO’s ‘access to essential medicines’ is fully integrated in UHC and PHC.
Access to Health Products - a key building block of universal health coverage Client: WHO (UHC/LC)
Equitable access to essential medical products, vaccines and technologies of assured quality, safety, efficacy and cost-effectiveness, and their scientifically sound and cost-effective use is one of the six health systems building blocks. To support countries to build their health systems to achieve universal health coverage (UHC) through a primary health care (PHC) approach, we designed the scope, structure, functions, and ways of working so that WHO’s ‘access to essential medicines’ is fully integrated in UHC and PHC.
Recent project
WHO: Shedding light on the Malaria Vaccine Market
The Yellow House conducted a Malaria Vaccine Market study involving consultations with global health stakeholders and vaccine developers/manufacturers in order to consolidate a product and supplier landscape and develop supply/demand scenarios through 2036 with WHO and Gavi. The Yellow House used the WHO MI4A methodology to consult with the MI4A advisory group and identify actions for global stakeholders.
Recent project
UNICEF: a lead implementation partner of the Access to COVID-19 Tools Accelerator (ACT-A)
UNICEF brought its technical expertise in programming, supply and logistics to ACT-A to help address the inequalities that exist in access to COVID-19 vaccines, tests, treatments. The Yellow House provided UNICEF with strategic and organizational advice on its contribution to accelerating access to Covid-19 tools. The work included engagement strategy, coordination mechanisms, as well as Covid-19 tool-specific analysis such as vaccine demand scenarios, procurement strategies, and options for diagnostics rollout.
Access to Health Products - a key building block of universal health coverage Client: WHO (UHC/LC)
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Access to Health Products - a key building block of universal health coverage Client: WHO (UHC/LC)
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Access to Health Products - a key building block of universal health coverage Client: WHO (UHC/LC)
Equitable access to essential medical products, vaccines and technologies of assured quality, safety, efficacy and cost-effectiveness, and their scientifically sound and cost-effective use is one of the six health systems building blocks. To support countries to build their health systems to achieve universal health coverage (UHC) through a primary health care (PHC) approach, we designed the scope, structure, functions, and ways of working so that WHO’s ‘access to essential medicines’ is fully integrated in UHC and PHC.
Access to Health Products - a key building block of universal health coverage Client: WHO (UHC/LC)
Equitable access to essential medical products, vaccines and technologies of assured quality, safety, efficacy and cost-effectiveness, and their scientifically sound and cost-effective use is one of the six health systems building blocks. To support countries to build their health systems to achieve universal health coverage (UHC) through a primary health care (PHC) approach, we designed the scope, structure, functions, and ways of working so that WHO’s ‘access to essential medicines’ is fully integrated in UHC and PHC.
Access to Health Products - a key building block of universal health coverage Client: WHO (UHC/LC)
Equitable access to essential medical products, vaccines and technologies of assured quality, safety, efficacy and cost-effectiveness, and their scientifically sound and cost-effective use is one of the six health systems building blocks. To support countries to build their health systems to achieve universal health coverage (UHC) through a primary health care (PHC) approach, we designed the scope, structure, functions, and ways of working so that WHO’s ‘access to essential medicines’ is fully integrated in UHC and PHC.
Recent project
FIND: Equitable access to reliable diagnosis around the world
The Yellow House supported FIND’s shift to a global alliance with CEO-level thought-partnership on the development of its new strategy including the what, the how, principles, and enablers. The focus was on optimizing diagnostic procurement and supply chains and landscaping the diagnostics ecosystem. The result was a shift from a primarily upstream focused work to an end-to-end approach – from R&D of novel diagnostics to their use at primary health care centers.
Recent project
Thought-partnership with the Colombia private sector
A few months into the onset of the coronavirus pandemic, The Yellow House provided analysis of Covid-19 vaccine development, contracts, and procurement channels to a private sector task force who was advising the government of Colombia on their Covid-19 vaccine access strategy.
Access to Health Products - a key building block of universal health coverage Client: WHO (UHC/LC)
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Access to Health Products - a key building block of universal health coverage Client: WHO (UHC/LC)
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Access to Health Products - a key building block of universal health coverage Client: WHO (UHC/LC)
Equitable access to essential medical products, vaccines and technologies of assured quality, safety, efficacy and cost-effectiveness, and their scientifically sound and cost-effective use is one of the six health systems building blocks. To support countries to build their health systems to achieve universal health coverage (UHC) through a primary health care (PHC) approach, we designed the scope, structure, functions, and ways of working so that WHO’s ‘access to essential medicines’ is fully integrated in UHC and PHC.
Access to Health Products - a key building block of universal health coverage Client: WHO (UHC/LC)
Equitable access to essential medical products, vaccines and technologies of assured quality, safety, efficacy and cost-effectiveness, and their scientifically sound and cost-effective use is one of the six health systems building blocks. To support countries to build their health systems to achieve universal health coverage (UHC) through a primary health care (PHC) approach, we designed the scope, structure, functions, and ways of working so that WHO’s ‘access to essential medicines’ is fully integrated in UHC and PHC.
Access to Health Products - a key building block of universal health coverage Client: WHO (UHC/LC)
Equitable access to essential medical products, vaccines and technologies of assured quality, safety, efficacy and cost-effectiveness, and their scientifically sound and cost-effective use is one of the six health systems building blocks. To support countries to build their health systems to achieve universal health coverage (UHC) through a primary health care (PHC) approach, we designed the scope, structure, functions, and ways of working so that WHO’s ‘access to essential medicines’ is fully integrated in UHC and PHC.
Read more about our health research and thought leadership:
